Logotype for Renovaro Inc

Renovaro (RENB) investor relations material

Renovaro Q1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Renovaro Inc
Q1 2026 earnings summary14 Nov, 2025

Executive summary

  • Achieved net income of $2.8M for Q3 2025, a significant improvement from a $44.2M net loss in Q3 2024, primarily due to the absence of prior year goodwill impairment and a gain from subsidiary bankruptcy.

  • Operating expenses decreased 94% year-over-year, driven by lower goodwill impairment and reduced general and administrative costs.

  • Completed the acquisition of BioSymetrics Inc. in April 2025, expanding AI-driven precision medicine capabilities.

  • Deconsolidated Gedi Cube B.V. following its bankruptcy, resulting in a $12M gain.

Financial highlights

  • Net income for Q3 2025 was $2.8M, compared to a net loss of $44.2M in Q3 2024.

  • Operating expenses fell to $3.3M from $53.3M year-over-year, mainly due to a $47.6M goodwill impairment in the prior year.

  • Cash increased to $624.8K as of September 30, 2025, up from $92.7K at June 30, 2025.

  • Working capital deficit improved to $18.9M from $28.1M sequentially.

  • Total assets were $7.0M and total liabilities $20.0M at quarter-end.

Outlook and guidance

  • Management is focused on streamlining operations around AI-driven neurology and oncology diagnostics and therapeutic development.

  • Additional funding is required to support ongoing operations and commercialization efforts; there is substantial doubt about the ability to continue as a going concern without new capital.

  • Funding received in fiscal 2026 will be used for obligations, product commercialization, clinical development, and working capital.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Renovaro earnings date

Logotype for Renovaro Inc
Q2 202613 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Renovaro earnings date

Logotype for Renovaro Inc
Q2 202613 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Renovaro Inc. is a biotechnology company focused on developing advanced allogeneic cell and gene therapies. These therapies are designed to enhance immune system responses with the potential for long-term or life-long remission in some of the most challenging cancers, as well as the treatment or possible cure of serious infectious diseases, including HIV and Hepatitis B virus (HBV). The company leverages its proprietary platforms in gene and cell therapy to create therapeutic candidates aimed at hyper-stimulating the immune system to target and destroy cancer cells and virus-infected cells. Renovaro Inc. is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage